Organization
Praxis Precision Medicines
7 clinical trials
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of PRAX-944 in the Treatment of Adults With Essential TremorStatus: Completed, Estimated PCD: 2023-02-09
Clinical trial
A Seamless, Clinical Trial to Investigate the Safety and Efficacy of Multiple Doses of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathyStatus: Active (not recruiting), Estimated PCD: 2025-07-01
Clinical trial
A Phase 2,Double-Blind,Randomized Clinical Trial to Explore the Safety,Tolerability,Efficacy, and Pharmacokinetics of PRAX-562 in Pediatric Participants With Developmental and Epileptic Encephalopathies Followed by Open-Label Extension(OLE)Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults With Essential TremorStatus: Completed, Estimated PCD: 2022-03-24
Clinical trial
Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Withdrawal, and Long-term Safety Study to Evaluate the Efficacy and Safety of Ulixacaltamide (PRAX-944) in Adults With Essential TremorStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Explore the Safety, Tolerability, Pharmacokinetics, and Efficacy of PRAX-114 in the Treatment of Adults With Essential TremorStatus: Withdrawn, Estimated PCD: 2022-06-30
Clinical trial
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress DisorderStatus: Terminated, Estimated PCD: 2022-08-01